U.S. federal trademark · Serial No. 87245470 · Reg. No. 6731937
Research and development of advanced learning technologies and teaching methods to identify approaches to extend the benefit of cancer immunotherapy to patients and collaborate to identify new treatment approaches, to rapidly initiate clinical trials and to aggregate and share data to accelerate progress in the field of cancer immunotherapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.